Allakos Stock (NASDAQ: ALLK) stock price, news, charts, stock research, profile.
Open | $1.06 |
Close | $1.00 |
Volume / Avg. | 8.55M / 477.21K |
Day Range | 0.93 - 1.06 |
52 Wk Range | 0.98 - 5.64 |
Market Cap | $87.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 8.16% |
Days to Cover | 10.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Allakos (NASDAQ:ALLK) through any online brokerage.
Other companies in Allakos’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO), FibroGen (NASDAQ:FGEN) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for Allakos.
Allakos has a consensus price target of $16.82.
The stock price for Allakos (NASDAQ: ALLK) is $0.99 last updated June 28, 2024 at 7:45 PM EDT.
There are no upcoming dividends for Allakos.
Allakos’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Allakos.
Allakos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.